Table 1 The basic information about the included studies
References | Definition of tumor-cell positivity | Detection method | Target gene/antigen | Follow-up (months) | Outcomes reported | stage | Multivariate analysis | |
|---|---|---|---|---|---|---|---|---|
Median | Range | |||||||
Chun-Dong Gu | LNMM | IHC | CK(AbAE1/A) | 44 | 4 –60 | OS | I | Yes |
Kazuhito Dobashi | LNMM | IHC | CK(AbAE1/A) | 13.6 | 1-60 | OS | pN0 | Yes |
B. Passlick | LNMM | IHC | CK | NR | NR | OS | pN0 | Yes |
Jakob R. Izbicki, | LNMM | IHC/FCM | Ber-Ep-4 | NR | 3-40 | DFS | pN0 | Yes |
By Toshihiro Osaki | LNMM | IHC | CK(AbAE1/A) | 35.8 | 0.1-90.6 | OS | I | Yes |
Kosei Yasumoto | LNMM | IHC | CK2 | 48.2 | 1-64 | OS/DFS | I | Yes |
Valerie W. Rusch | LNMM | IHC | CK(AE-1) | NR | 0-60 | OS/DFS | pN0 | Yes |
Wang Zhou | LNMM | RT-PCR | MUC1 | NR | 0-36 | OS | pN0 | Yes |